Fig. 1: Proposed algorithm for the management of high-risk and/or relapsed/refractory CTCL. | Bone Marrow Transplantation

Fig. 1: Proposed algorithm for the management of high-risk and/or relapsed/refractory CTCL.

From: Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee

Fig. 1: Proposed algorithm for the management of high-risk and/or relapsed/refractory CTCL.The alternative text for this image may have been generated using AI.

MF mycosis fungoides, SS Sezary syndrome, allo-HCT allogeneic hematopoietic cell transplantation, CR complete remission, PR partial remission, VGPR very good PR, SD stable disease, PD progressive disease, RIC reduced intensity conditioning. α: patients with SS, rare entities or large cell transformation should be considered to allo-HCT regardless on the line of treatment, in CR or PR; β: according to age, PS, comorbidities; γ: According to center preference; δ: GVHD prophylaxis should follow general guidelines for allo-HCT.

Back to article page